Experience with emetine hydrochloride (NSC 33669) as an antitumor agent. [electronic resource]
Producer: 19710628Description: 835-41 p. digitalISSN:- 0008-543X
- Adenocarcinoma -- drug therapy
- Antineoplastic Agents -- adverse effects
- Breast Neoplasms -- drug therapy
- Carcinoma, Bronchogenic -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Carcinoma, Transitional Cell -- drug therapy
- Colonic Neoplasms -- drug therapy
- Diarrhea -- chemically induced
- Electrocardiography
- Emetine -- administration & dosage
- Female
- Humans
- Injections, Intravenous
- Laryngeal Neoplasms -- drug therapy
- Leukemia, Lymphoid -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Melanoma -- drug therapy
- Myositis -- chemically induced
- Nausea -- chemically induced
- Tachycardia -- chemically induced
- Thyroid Neoplasms -- drug therapy
- Tracheal Neoplasms -- drug therapy
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.